Cellink
Gothenburg
About Cellink
Cellink is a biotechnology company and one of the first bioink companies in the world. The company leverages its bioink and 3D printing technology to print human organs and tissue models, which potentially can be used in e.g. oncology research, drug testing, and cosmetic testing. The company’s vision is to create the future of medicine by making bioprinting technology as accessible, user-friendly, and high performing as possible. Cellink has offices in Gothenburg, Sweden, and Palo Alto, California, and collaborates with different organizations across the globe.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 251 – 500
- Estimated revenue: $50K – $100K
- Total funding: $4.3M
- Funding stage: IPO
- Last round: Grant (Mar 2020)
- Ticker: otcpink:CLKKF
- Website: cellink.com
- Phone: +46 31-12 87 00
Industries & Categories
3D Printing, Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/cellink-148604 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.